BETA: Please send your feedback!
Aclaris Therapeutics
ACRS:NAS
Pharmaceuticals: Other
$0
SMALL cap
$1.66
(0.04%)
-0.76%
since start of 2019
-0.37
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 2012
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.
website
Headquarters
Executives
Name | Title | Gender |
Neal S. Walker, PhD, MBA | President, Chief Executive Officer & Director | Male |
Michael Stephen Tung, MD, MBA | Vice President-Investor Relations | Male |
Stephen A. Tullman | Chairman | Male |
Kamil Ali-Jackson | Chief Legal Officer | Female |
Frank Ruffo, CPA | Chief Financial Officer | Male |
Christopher V. Powala | Chief Operating Officer | Male |
Stuart D. Shanler, MD | Chief Scientific Officer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Aclaris Therapeutics - Competitors and Related Companies
How Aclaris Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Aclaris Therapeutics
ACRS:NAS
Pharmaceuticals: Other
$0
SMALL cap
$1.66
(0.04%)
-0.76%
since start of 2019
-0.37
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5
Omeros
OMER:NAS
Biotechnology
$654.68mm
SMALL cap
$13.16
(-0.15%)
0.10%
since start of 2019
-8.20
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5
Onconova Therapeutics
ONTX:NAS
Biotechnology
$2.87mm
MICRO cap
$0.35
(0.06%)
-0.66%
since start of 2019
-0.10
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5
Ophthotech
OPHT:NAS
Biotechnology
$0
MICRO cap
$1.44
(0.00%)
0.13%
since start of 2019
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5
Ono Pharmaceutical
4528-JP:TKS
Pharmaceuticals: Other
—
LARGE cap
(—)
—
since start of 2019
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
- —
- 1
- 2
- 3
- 4
- 5